Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.63 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.63 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.63 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.63 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.63 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29617387 | 1.00 | HPGD (0.63) | HPGDALOX15MEN1KMT2AGRIN2D | |
| SCHEMBL9452343 | 0.88 | ALOX15 (0.50) | HPGDALOX15MEN1KMT2AGRIN2D | |
| SCHEMBL9452270 | 0.88 | ALOX15 (0.56) | HPGDALOX15MEN1KMT2AGRIN2D | |
| SCHEMBL9452263 | 0.87 | ALOX15 (0.55) | HPGDALOX15MEN1KMT2AGRIN2D | |
| SCHEMBL9452307 | 0.87 | ALOX15 (0.49) | HPGDALOX15MEN1KMT2AGRIN2D | |
| SCHEMBL9452300 | 0.85 | CYP1A2 (0.68) | HPGDALOX15MEN1KMT2AGRIN2D | |
| SCHEMBL9452253 | 0.84 | TSHR (0.54) | HPGDALOX15MEN1KMT2AGRIN2D | |
| Bromide SCHEMBL9452238 | 0.83 | TSHR (0.53) | HPGDALOX15MEN1KMT2AGRIN2D | |
| SCHEMBL9452191 | 0.82 | ALOX15 (0.54) | HPGDALOX15MEN1KMT2AGRIN2D | |
| SCHEMBL9501035 | 0.82 | ALOX15 (0.54) | HPGDALOX15MEN1KMT2AGRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4227297-A1 | PROCESS FOR PREPARING DIPHENYLUREIDO-DIHALOKYNURENIC ACIDS AND TOSYLATE ADDITION SALTS THEREOF | Lohocla Research Corporation (US) | 2023-08-16 | — | — | EP | disclosed |
| EP-4227297-A1 | PROCESS FOR PREPARING DIPHENYLUREIDO-DIHALOKYNURENIC ACIDS AND TOSYLATE ADDITION SALTS THEREOF | Lohocla Research Corporation (US) | 2023-08-16 | — | — | EP | disclosed |
| EP-4013416-A1 | PROCESS FOR PREPARING 1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLATES AND 4-AMINOQUINOLINE COMPOUNDS THEREFROM | Lohocla Research Corporation (US) | 2022-06-22 | — | — | EP | disclosed |
| US-20220162168-A1 | PROCESS FOR PREPARING DIPHENYLUREIDO-DIHALOKYNURENIC ACIDS AND TOSYLATE ADDITION SALTS THEREOF | LOHOCLA RESEARCH CORPORATION | 2022-05-26 | — | — | US | disclosed |
| US-20220162168-A1 | PROCESS FOR PREPARING DIPHENYLUREIDO-DIHALOKYNURENIC ACIDS AND TOSYLATE ADDITION SALTS THEREOF | LOHOCLA RESEARCH CORPORATION | 2022-05-26 | — | — | US | disclosed |
| WO-2021030511-A1 | PROCESS FOR PREPARING 1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLATES AND 4-AMINOQUINOLINE COMPOUNDS THEREFROM | LOHOCLA RESEARCH CORPORATION (US) | 2021-02-18 | — | — | WO | disclosed |
| WO-2021030511-A1 | PROCESS FOR PREPARING 1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLATES AND 4-AMINOQUINOLINE COMPOUNDS THEREFROM | LOHOCLA RESEARCH CORPORATION (US) | 2021-02-18 | — | — | WO | disclosed |
| US-10875831-B1 | Process for preparing 1,4-dihydro-4-oxoquinoline-2-carboxylates and 4-aminoquinoline compounds therefrom | LOHOCLA RESEARCH CORPORATION (US) | 2020-12-29 | — | — | US | disclosed |
| US-10875831-B1 | Process for preparing 1,4-dihydro-4-oxoquinoline-2-carboxylates and 4-aminoquinoline compounds therefrom | LOHOCLA RESEARCH CORPORATION (US) | 2020-12-29 | — | — | US | disclosed |
| US-20110184018-A1 | METHOD FOR TREATING PERIPHERAL NEUROPATHIC PAIN | LOHOCLA RESEARCH CORPORATION (US) | 2011-07-28 | — | — | US | disclosed |
| US-20110184018-A1 | METHOD FOR TREATING PERIPHERAL NEUROPATHIC PAIN | LOHOCLA RESEARCH CORPORATION (US) | 2011-07-28 | — | — | US | disclosed |
| US-7923458-B2 | Method for treating chronic pain | LOHOCLA RESEARCH CORPORATION (US) | 2011-04-12 | — | — | US | disclosed |
| US-7923458-B2 | Method for treating chronic pain | LOHOCLA RESEARCH CORPORATION (US) | 2011-04-12 | — | — | US | disclosed |
| US-7923458-B2 | Method for treating chronic pain | LOHOCLA RESEARCH CORPORATION (US) | 2011-04-12 | — | — | US | disclosed |
| US-20090137627-A1 | Method for Treating Chronic Pain | LOHOCLA RESEARCH CORPORATION | 2009-05-28 | — | — | US | disclosed |
| US-20090137627-A1 | Method for Treating Chronic Pain | LOHOCLA RESEARCH CORPORATION | 2009-05-28 | — | — | US | disclosed |
| US-20090137627-A1 | Method for Treating Chronic Pain | LOHOCLA RESEARCH CORPORATION | 2009-05-28 | — | — | US | disclosed |
| EP-1951238-A2 | METHOD FOR TREATING CHRONIC PAIN | Lohocla Research Corporation (US) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007044682-A2 | METHOD FOR TREATING CHRONIC PAIN | LOHOCLA RESEARCH CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |
| WO-2007044682-A2 | METHOD FOR TREATING CHRONIC PAIN | LOHOCLA RESEARCH CORPORATION (US) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137627-A1 | Method for Treating Chronic Pain | OPRK1, AADAT, BDKRB2 | HPGD 25/4885ALOX15 56/4885MEN1 4244/4885 |
| US-20110184018-A1 | METHOD FOR TREATING PERIPHERAL NEUROPATHIC PAIN | CNR1, CNR2, OPRK1 | HPGD 285/4885ALOX15 150/4885MEN1 3740/4885 |
| US-10875831-B1 | Process for preparing 1,4-dihydro-4-oxoquinoline-2-carboxylates and 4-aminoquinoline compounds therefrom | KMO, THEM6, HADHA | HPGD 337/4885ALOX15 136/4885MEN1 1735/4885 |
| US-20220162168-A1 | PROCESS FOR PREPARING DIPHENYLUREIDO-DIHALOKYNURENIC ACIDS AND TOSYLATE ADDITION SALTS THEREOF | KMO, KYNU, PAH | HPGD 281/4885ALOX15 58/4885MEN1 637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.